Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
BMJ 2006;333 (28 October), doi:10.1136/bmj.333.7574.0-d
Patients' renal function and electrolyte concentrations should be monitored as part of treatment evaluation in hypertension because several classes of antihypertensives can lead to poor renal perfusion and abnormal electrolyte concentrations. In this guide to good practice, Martin and Coleman (p 896) examine two cases where drug treatment of hypertension precipitated serious problems detected by blood electrolyte analysis. The authors highlight the high incidence of underlying renovascular disease in patients with hypertension and issue caution about using potassium sparing agents.
|
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?